Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Allen Robert D. III, Chief Scientific Officer. Officer active across 1 company, notably Invivyd, Inc.. Aggregated, 7 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €49k. History available since 19 August 2025. The latest transaction was filed on 17 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Robert D. Allen III is the Chief Scientific Officer at Invivyd, Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and scientific advancement. With a strong background in science, he plays a crucial role in product strategy and the development of new technologies. His expertise contributes to the company's mission of improving health and well-being.